Cited by 50Cancer, Hypoxia, and MetabolismMedical Imaging Techniques and ApplicationsHead and Neck Cancer Studies

Tumor Hypoxia Imaging

Serganova, Inna, Humm, John, Ling, Clifton, Blasberg, Ronald·2006·Clinical Cancer Research

Abstract

In this issue of Clinical Cancer Research , Rajendran et al. ([1][1]) have assessed the value of pretherapy fluoromisonidazole (FMISO) positron emission tomography (PET) imaging, an indicator of tissue hypoxia, in predicting survival of 73 patients with head and neck cancers. In this study, the

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-06-0517

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The parallel use of FDG-PET and FMISO gives the best assessment of tumor tissue hypoxia in clinical situations.

    “The parallel use of the two technologies give the best assessment of tumor tissue hypoxia in clinical situations [56, 57].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Serganova, I., Humm, J., Ling, C., & Blasberg, R.
Affiliations
  • 1Neurology, Departments of
  • 2Radiology, and
  • Memorial Sloan Kettering Cancer Center (US)
Venue
Clinical Cancer Research
Published
2006-09-15
Volume
12
Issue
18
Pages
5260-5264
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2040661938
Cited by
50
References
56
Citations by year
2026: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 1
FWCI
1.70
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r01ca083066-01)
  • National Cancer Institute (R01CA084596, P01CA059017, P01-CA-59017, R21CA093501, P50CA86438, P50CA086438, R01CA102673, R01 CA83066, R01 CA84596)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
tumor hypoxia, fluoromisonidazole, FMISO PET, head and neck cancer, survival prediction
MeSH terms
Humans, Misonidazole, Models, Biological, Neoplasm Metastasis, Neoplasms, Oxygen, Biomarkers, Cell Hypoxia, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review